Row, New York, NY, 1974, p 400.
Materials and Methods
The control group consisted of 18 ostensibly healthy blood donors, most of them men, with no clinical signs of diabetes mellitus. The 122 diabetic patients were regularly attending our outpatient service for diabetic care. They were being treated with insulin, sulfonylurea drugs, or diet alone. Blood samples for HbA1 determinations, obtained after an overnight fast, were drawn in EDTA-containing tubes, unless otherwise stated. They were analyzed concomitantly by the microchromatographic and the spectrophotometric methods. HbA1 analysis by the use of microcolumns was performed with a commercial kit (Bio-Rad Laboratories, Richmond, CA 94804). Blood was drawn into EDTA-containing tubes, if not otherwise stated, and was mixed with a hemolysing reagent.
An aliquot of each hemolysate was applied to the microcolumn. Adding the elution buffer rapidly eluted HbA1 from the column, while the main part of the hemoglobin was retarded. The percentage of HbA1 in the blood samples was determined by measuring the absorbance at 415 nm of the eluted HbA1 fraction and the dilutedhemolysate. The eluantbufferwas keptat22 #{176}C, thetemperaturebeingcontinuously monitored with a microelectrode inserted into the resin. Values deviating from 22#{176}C were corrected according to a nomogram provided by the manufacturer.
The spectrophotometric assay is based on the fact that organophosphorus compounds such as 2,3-diphosphoglycerate (2,3-DPG) and inositol hexaphosphate (phytic acid) bind to the N-terminal amino acid of the two beta chains of hemoglobin A (10). This causes a conformational change of the hemoglobin molecule, a process that can be monitored spectrophotometrically.
The prerequisite for such a change is available N-terminal residues. Hence, the spectrum of glycosylated hemoglobin is not changed by the organophosphorus compounds because of the blocking effect of the glucose moiety. The change in absorbance induced by phytic acid is thus inversely proportional to the percentage of glycosylated hemoglobin.
The spectrophotometric assay was done in accordance with themanufacturer's instructions with a kit (Glycospec; Abbott Laboratories, North Chicago, IL 60064) and an Abbott automated bichromatic analyzer (the ABA-100). An aliquot of each blood sample (drawn in EDTA-containing tubes) or standard was pipetted into the ABA sample cups. l1en micriliters of each sample was automatically dispensed with 500 sL of hemolysing reagent into the appropriate cuvette and the dif- 
Results Precision
The within-assay precision of the two methods was determined for two concentrations of HbA1 (Table 1 ). The coefficient of variation (CV) was acceptable for both methods but was less with the Bio-Rad method, especially at low HbA, values. The within-assay precision of the Glycospec method was further explored by analyzing 23 different blood samples in duplicate on one occasion. The mean HbA1 value was 14.4%, and by adopting a special formula' the SD and CV were found to be 0.63% and 4.4%, respectively (11) .
The between-assay CV for the two methods at five different HbA, concentrations is shown in Table 2 . The difference between the methods was small. The Bio-R.ad method afforded slightly lower CV values.
HbA1 Values in Normal and Diabetic Subjects
In healthy subjects the mean (and SD) HbA1 value was 7.7 (1.3)% with the Glycospec and 6.8 (0.6)% with the Bio-Rad method. In the diabetic group the corresponding values were 14.0 (28)% and 11.0 (2.2)%, respectively. Again, higher values were obtained with the Glycospec method, and the discrepancy was most pronounced in the diabetic group.
The correlation between the HbA1 values obtained with the two methods in the diabetic group was satisfactory (r = 0.89) 1 
SD =
x,)' , where n is the number of samples.
as shown in Figure 1 . The HbA1 values obtained with the Glycospec method were generally 2-4% higher than those obtained with the Bio-Rad method.
Effect of Storage and Anticoagulant Treatment
Storage of blood samples for several days affected the HbA1 values differently, depending on the assay used (Figure 2) . Thus, the HbA, concentrations insamples withinitially low concentrations stored at 22 #{176}C increased as determined with theGlycospec method;withtheBio-Rad method theincrease was much less. Storageat4 #{176}C forat least10 days did not significantly influence HbA1 values obtained by either of the two methods. The effect of EDTA and heparin on the HbA, values obtained by the two methods was also examined (Table3).With the Glycospecmethod, heparmn-treated samplesyieldedsignificantly higher HbA1 values; with the Bio-Rad method they were slightly lower.
influence of 2,3-DPG on the HbA1 Values Obtained with the Spectrophotometric Method
Because phytic acid and 2,3-DPG bind to the same region of the hemoglobin molecule it was of interest to study the influence of exogenous 2,3-DPG on the spectrophotometric assay. Figure 3 illustrates the increase in HbA1 values when increasing amounts of 2,3-DPG were added to the blood samples before assay. A saturation was not evident, even at a concentration of added 2,3-DPG in the sample to be assayed as high as 23 mmol/L. A similar effect was obvious when 2,3-DPG was added to the three different HbA1 standards The standards were statedto contain 1.8,7.7, and 17.2% HbA1.Standardcwve A was obtainedwithoutadded2,3-DPG; B, C, D, andEafter additionof 2,3-OPG to a final concentration in the sample to be assayed011.8, 3.6, 7.7, and 11.1 mmoi/L respectively. "A A normalized" is the difference between the absorption recordingsin the absenceand presence of phytic acid, corrected for total hemoglobin provided in the kit. The displacement of the standard curves after addition of 2,3-DPG is shown in Figure 4 .
Discussion
The two methods displayed similar precision and reproducibility, although they represent different principles for the determination of HbA1. The spectrophotometric method yielded consistently higher values than the microcolumn method, more obvious in diabetics than in normal subjects.
Investigating possible reasons for this discrepancy, we found that 2,3-DPG caused a dose-related displacement of the standard curves of the spectrophotometric method. Furthermore, when 2,3-DPG was added to blood samples an approximately linear relationship was found between increase in percentage HbA, and added amounts of 2,3-DPG. These results are consistent with a competition between 2,3-DPG and phytic acid for the same binding region in the hemoglobin molecule. Even at a 2,3-DPG concentration of 23 mmol/L (corresponding to 0.4 mmolfL in the final assay mixture) the percentage increase in HbA1 was nonsaturable. The concentration of phytic acid in the assay samples was 0.12 mmol/L, which means that phytic acid competes well with 2,3-DPG, even at a three-or fourfold excess of 2,3-DPG.
According to the manufacturer, the Glycospec HbA, standards contain no 2,3-DPG (personal communication from Dr.
E. G. Moore). In contrast, the concentration of 2,3-DPG in
whole blood is about 2 mmolfL, as estimated from the 2,3-DPG content of erythrocytes reported by Ditzel and Standi (12) . At this concentration of 2,3-DPG the standard curve yields 2-3% lower HbA1 values for a certain absorbance difference than those obtained from a standard curve with no added 2,3-DPG (cf. Figure 4) . If the Glycospec values are corrected for this effect of 2,3-DPG, they then match those. suggests that conformational changes of the hemoglobin molecule are of less importance for the chromatographic separation and elution of the glycohemoglobins.
The HbA1 fraction determined with the microcolumn method is heterogeneous.2The spectrophotometric method seems to be more specific, because it measures only hemoglobin glycosylation at the N-terminal of the beta chains. However, compounds such as 2,3-DPG interfering at this region of the hemoglobin molecule might introduce an error. Furthermore, it is not known to what extent the labile Schiff base of HbAj is measured. The presence of hemoglobin F in the samplesgivesa false increasein the HbA1 value with both methods2 (10 
